- Investing Ideas
- /
- Household Healthcare Sector
Household Healthcare Sector
Results
2305
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2305 companies
AN2 Therapeutics
Market Cap: US$35.8m
A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.
ANTX
US$1.17
7D
-3.3%
1Y
-42.1%
Proteomics International Laboratories
Market Cap: AU$55.0m
Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and South East Asia.
PIQ
AU$0.42
7D
12.0%
1Y
-58.8%
Envoy Medical
Market Cap: US$35.5m
A hearing health company, focuses on providing medical technologies across the hearing loss spectrum.
COCH
US$1.63
7D
-3.0%
1Y
-40.9%
Simply Solventless Concentrates
Market Cap: CA$48.7m
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
HASH
CA$0.48
7D
1.1%
1Y
128.6%
MedAdvisor
Market Cap: AU$54.4m
Provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom.
MDR
AU$0.087
7D
0%
1Y
-79.5%
Pluri
Market Cap: US$35.1m
A biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries.
PLUR
US$4.50
7D
-13.6%
1Y
-25.2%
NeuroSense Therapeutics
Market Cap: US$35.0m
A clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally.
NRSN
US$1.52
7D
15.2%
1Y
30.2%
Oncolytics Biotech
Market Cap: CA$48.1m
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.
ONC
CA$0.55
7D
-15.4%
1Y
-63.1%
Boundless Bio
Market Cap: US$34.9m
A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).
BOLD
US$1.54
7D
-6.7%
1Y
-86.4%
Microbix Biosystems
Market Cap: CA$47.9m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.34
7D
-2.9%
1Y
6.3%
Provectus Biopharmaceuticals
Market Cap: US$34.8m
A clinical-stage biotechnology company, engages in developing immunotherapy medicines different diseases in the United States.
PVCT
US$0.087
7D
5.1%
1Y
-51.3%
Burning Rock Biotech
Market Cap: US$34.8m
Primarily develops and sells cancer therapy selection tests in the People's Republic of China.
BNR
US$3.25
7D
14.0%
1Y
-57.0%
Spectral AI
Market Cap: US$34.7m
An artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
MDAI
US$1.46
7D
5.8%
1Y
-9.9%
Aligos Therapeutics
Market Cap: US$34.7m
A clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases.
ALGS
US$5.50
7D
-5.8%
1Y
-62.1%
Coeptis Therapeutics Holdings
Market Cap: US$34.6m
Operates as a biopharmaceutical company.
COEP
US$10.41
7D
6.1%
1Y
80.9%
Shield Therapeutics
Market Cap: UK£25.5m
A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.
STX
UK£0.025
7D
4.3%
1Y
2.1%
KDA Group
Market Cap: CA$47.1m
Provides technological solutions to general and specialized health sectors in Canada.
KDA
CA$0.25
7D
0%
1Y
-33.3%
Concord Medical Services Holdings
Market Cap: US$34.2m
Through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China.
CCM
US$7.02
7D
-16.5%
1Y
4.9%
Golden Valley Development
Market Cap: US$34.2m
Through its subsidiaries, manufactures and markets patented products in the health care and home consumer markets sectors.
GVDI
US$0.05
7D
0%
1Y
n/a
Reliq Health Technologies
Market Cap: CA$47.3m
A healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market.
RHT
CA$0.21
7D
0%
1Y
-57.0%
InnoCan Pharma
Market Cap: CA$46.8m
A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.
INNO
CA$0.16
7D
-5.9%
1Y
-48.4%
Rockwell Medical
Market Cap: US$34.1m
Develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide.
RMTI
US$0.98
7D
-3.0%
1Y
-45.9%
Defence Therapeutics
Market Cap: CA$46.5m
Develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases.
DTC
CA$0.85
7D
-7.6%
1Y
-29.2%
Rafael Holdings
Market Cap: US$33.6m
Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel.
RFL
US$1.39
7D
-2.8%
1Y
-12.6%
Precision Optics Corporation
Market Cap: US$33.6m
Designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
POCI
US$4.34
7D
-4.1%
1Y
-33.9%
Tryptamine Therapeutics
Market Cap: AU$51.8m
A clinical-stage pharmaceutical development company, focuses on developing synthetic psilocybin-related molecules in Australia, Canada, Switzerland, and the United States.
TYP
AU$0.036
7D
0%
1Y
n/a
LAVA Therapeutics
Market Cap: US$33.4m
Operates as a clinical-stage immuno-oncology company that focuses on developing cancer treatments.
LVTX
US$1.28
7D
2.4%
1Y
-51.5%
FibroGen
Market Cap: US$33.2m
A biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.
FGEN
US$0.33
7D
7.8%
1Y
-74.6%
OS Therapies
Market Cap: US$33.1m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$1.68
7D
2.4%
1Y
n/a
FibroBiologics
Market Cap: US$32.9m
Operates as a cell therapy, regenerative medicine company.
FBLG
US$0.81
7D
-13.3%
1Y
-92.9%
Ocumetics Technology
Market Cap: CA$44.9m
Engages in research, development, production, and sale of vision enhancement products in Canada.
OTC
CA$0.38
7D
8.7%
1Y
27.1%
Barinthus Biotherapeutics
Market Cap: US$32.7m
A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.
BRNS
US$0.65
7D
-30.7%
1Y
-70.4%
Abingdon Health
Market Cap: UK£23.5m
Operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally.
ABDX
UK£0.063
7D
2.5%
1Y
-43.2%
INOVIQ
Market Cap: AU$49.1m
Engages in the developing and commercializing of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States.
IIQ
AU$0.44
7D
17.3%
1Y
-8.3%
Radiopharm Theranostics
Market Cap: AU$49.0m
Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.
RAD
AU$0.021
7D
-4.5%
1Y
-36.4%
Dyadic International
Market Cap: US$31.6m
A biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally.
DYAI
US$1.00
7D
-4.3%
1Y
-48.9%